BioVNN

BioVNN predicts cancer dependencies by integrating biological pathway knowledge into a visible neural network architecture to provide interpretable, pathway-informed predictions.


Key Features:

  • Pathway Knowledge Integration: BioVNN embeds detailed biological pathway information into its neural architecture and enables correlating predictions with neuron output states of relevant pathways.
  • Interpretable Predictions: The model provides interpretability by correlating dependency predictions with neuron output states, allowing inference of pathway-level contributions to dependencies.
  • Performance Efficiency: Despite using fewer parameters than conventional neural networks, BioVNN marginally outperforms traditional NNs and converges faster during training.
  • Comparison with Randomized Pathways: In comparative analyses, BioVNN significantly outperforms a neural network based on randomized pathways.
  • Feature Importance Analysis: Feature importance analysis recapitulates known reaction partners and proposes novel ones, expanding understanding of cancer dependency networks.

Scientific Applications:

  • Oncology research: Identify potential drug targets by predicting cancer dependencies.
  • Mechanistic exploration: Use interpretable neuron output states to explore mechanisms underlying cancer dependencies.
  • Therapeutic development: Inform development of targeted therapies by linking dependencies to specific pathway components.
  • Personalized medicine: Support tailoring predictions to specific cancers or individual patients.

Methodology:

BioVNN implements visible neural networks that incorporate pathway knowledge into the model architecture, and achieves interpretability by correlating dependency predictions with neuron output states.

Topics

Details

License:
MIT
Tool Type:
command-line tool
Programming Languages:
Python
Added:
6/14/2021
Last Updated:
11/24/2024

Operations

Publications

Lin C, Lichtarge O. Using interpretable deep learning to model cancer dependencies. Bioinformatics. 2021;37(17):2675-2681. doi:10.1093/bioinformatics/btab137. PMID:34042953. PMCID:PMC8428607.

PMID: 34042953
PMCID: PMC8428607
Funding: - National Institutes of Health: AG061105, NIH-GM066099, NIH-GM079656

Downloads

Links